Tags

Type your tag names separated by a space and hit enter

[Therapy of hyperuricemia and gout].
Wien Med Wochenschr. 1997; 147(16):382-7.WM

Abstract

Therapy of hyperuricemia and gout has to depend on pathogenesis and stage of the disease. Dietary regimen are in the forefront in treatment of asymptomatic hyperuricemia. Uric acid lowering drugs can only be supported in repeated serum-measures from 9 mg/dl up. The therapy of an acute attack of gout primarily is done with non-steroidal antiinflammatory drugs, in rare cases with colchicine or corticoids. Gouty arthritis in intermission, independent of the extent of hyperuricemia, as well as chronic gout are indications for an uric acid lowering pharmacotherapy, usually for life. A special therapeutic challenge arises out of renal complications and the frequent association with the metabolic syndrome.

Authors+Show Affiliations

Pöllmann G
Sonderkrankenanstalt für rheumatische Erkrankungen und Herzkreislaufkrankheiten der Pensionsversicherungsanstalt für Arbeiter, Saalfelden.
Kullich W
No affiliation info available
Klein G
No affiliation info available

MeSH

Acute DiseaseAdrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalArthritis, GoutyColchicineGoutGout SuppressantsHumansUric Acid

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

9446417

Citation

Pöllmann, G, et al. "[Therapy of Hyperuricemia and Gout]." Wiener Medizinische Wochenschrift (1946), vol. 147, no. 16, 1997, pp. 382-7.
Pöllmann G, Kullich W, Klein G. [Therapy of hyperuricemia and gout]. Wien Med Wochenschr. 1997;147(16):382-7.
Pöllmann, G., Kullich, W., & Klein, G. (1997). [Therapy of hyperuricemia and gout]. Wiener Medizinische Wochenschrift (1946), 147(16), 382-7.
Pöllmann G, Kullich W, Klein G. [Therapy of Hyperuricemia and Gout]. Wien Med Wochenschr. 1997;147(16):382-7. PubMed PMID: 9446417.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Therapy of hyperuricemia and gout]. AU - Pöllmann,G, AU - Kullich,W, AU - Klein,G, PY - 1997/1/1/pubmed PY - 1998/1/31/medline PY - 1997/1/1/entrez SP - 382 EP - 7 JF - Wiener medizinische Wochenschrift (1946) JO - Wien Med Wochenschr VL - 147 IS - 16 N2 - Therapy of hyperuricemia and gout has to depend on pathogenesis and stage of the disease. Dietary regimen are in the forefront in treatment of asymptomatic hyperuricemia. Uric acid lowering drugs can only be supported in repeated serum-measures from 9 mg/dl up. The therapy of an acute attack of gout primarily is done with non-steroidal antiinflammatory drugs, in rare cases with colchicine or corticoids. Gouty arthritis in intermission, independent of the extent of hyperuricemia, as well as chronic gout are indications for an uric acid lowering pharmacotherapy, usually for life. A special therapeutic challenge arises out of renal complications and the frequent association with the metabolic syndrome. SN - 0043-5341 UR - https://www.unboundmedicine.com/medline/citation/9446417/[Therapy_of_hyperuricemia_and_gout]_ L2 - https://medlineplus.gov/gout.html DB - PRIME DP - Unbound Medicine ER -